143 related articles for article (PubMed ID: 25986246)
21. The change of the neuron-glia differentiation rate in human neural precursor cells (HPCs) and Ad-BDNF-/-GDNF-infected HPCs following the administration of a neurotoxin.
Yoo YM; Kim YJ; Lee U
Neurosci Lett; 2005 Oct; 387(2):100-4. PubMed ID: 16081212
[TBL] [Abstract][Full Text] [Related]
22. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity.
Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D
Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798
[TBL] [Abstract][Full Text] [Related]
23. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine.
Rodriguez-Blanco J; Martín V; Herrera F; García-Santos G; Antolín I; Rodriguez C
J Neurochem; 2008 Oct; 107(1):127-40. PubMed ID: 18665912
[TBL] [Abstract][Full Text] [Related]
24. Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model.
Zhang X; Andren PE; Svenningsson P
Physiol Behav; 2007 Sep; 92(1-2):29-33. PubMed ID: 17588622
[TBL] [Abstract][Full Text] [Related]
25. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease.
Carvey PM; Ling ZD; Sortwell CE; Pitzer MR; McGuire SO; Storch A; Collier TJ
Exp Neurol; 2001 Sep; 171(1):98-108. PubMed ID: 11520124
[TBL] [Abstract][Full Text] [Related]
26. Protective and restorative effects of magnolol on neurotoxicity in mice with 6-hydroxydopamine-induced hemiparkinsonism.
Chen HH; Lin SC; Chan MH
Neurodegener Dis; 2011; 8(5):364-74. PubMed ID: 21494012
[TBL] [Abstract][Full Text] [Related]
27. Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats.
Teixeira MD; Souza CM; Menezes AP; Carmo MR; Fonteles AA; Gurgel JP; Lima FA; Viana GS; Andrade GM
Pharmacol Biochem Behav; 2013 Sep; 110():1-7. PubMed ID: 23714698
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
Kumar A; Sharma N; Gupta A; Kalonia H; Mishra J
Brain Res; 2012 Aug; 1471():13-22. PubMed ID: 22789904
[TBL] [Abstract][Full Text] [Related]
29. RA410/Sly1 suppresses MPP+ and 6-hydroxydopamine-induced cell death in SH-SY5Y cells.
Bando Y; Katayama T; Taniguchi M; Ishibashi T; Matsuo N; Ogawa S; Tohyama M
Neurobiol Dis; 2005 Feb; 18(1):143-51. PubMed ID: 15649705
[TBL] [Abstract][Full Text] [Related]
30. 6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging.
Kondoh T; Bannai M; Nishino H; Torii K
Exp Neurol; 2005 Mar; 192(1):194-202. PubMed ID: 15698634
[TBL] [Abstract][Full Text] [Related]
31. Effects of discontinuing a high-fat diet on mitochondrial proteins and 6-hydroxydopamine-induced dopamine depletion in rats.
Ma D; Shuler JM; Raider KD; Rogers RS; Wheatley JL; Geiger PC; Stanford JA
Brain Res; 2015 Jul; 1613():49-58. PubMed ID: 25862572
[TBL] [Abstract][Full Text] [Related]
32. The Docosanoid Neuroprotectin D1 Induces TH-Positive Neuronal Survival in a Cellular Model of Parkinson's Disease.
Calandria JM; Sharp MW; Bazan NG
Cell Mol Neurobiol; 2015 Nov; 35(8):1127-36. PubMed ID: 26047923
[TBL] [Abstract][Full Text] [Related]
33. The effect of thrombin on a 6-hydroxydopamine model of Parkinson's disease depends on timing.
Cannon JR; Hua Y; Richardson RJ; Xi G; Keep RF; Schallert T
Behav Brain Res; 2007 Nov; 183(2):161-8. PubMed ID: 17629581
[TBL] [Abstract][Full Text] [Related]
34. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.
Chan WS; Durairajan SS; Lu JH; Wang Y; Xie LX; Kum WF; Koo I; Yung KK; Li M
Neurochem Int; 2009 Nov; 55(6):414-22. PubMed ID: 19409437
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson's disease.
Cova L; Bossolasco P; Armentero MT; Diana V; Zennaro E; Mellone M; Calzarossa C; Cerri S; Deliliers GL; Polli E; Blandini F; Silani V
Apoptosis; 2012 Mar; 17(3):289-304. PubMed ID: 22160861
[TBL] [Abstract][Full Text] [Related]
38. DJ-1 protein protects dopaminergic neurons against 6-OHDA/MG-132-induced neurotoxicity in rats.
Sun SY; An CN; Pu XP
Brain Res Bull; 2012 Sep; 88(6):609-16. PubMed ID: 22664331
[TBL] [Abstract][Full Text] [Related]
39. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
[TBL] [Abstract][Full Text] [Related]
40. Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease.
Kwon IH; Choi HS; Shin KS; Lee BK; Lee CK; Hwang BY; Lim SC; Lee MK
Neurosci Lett; 2010 Dec; 486(1):29-33. PubMed ID: 20851167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
